Ezgi Tasdemir, PhD
About Ezgi Tasdemir, PhD
Ezgi Tasdemir, PhD, is the General Manager for France & BeLux at BeiGene, based in Milan, Italy. She has extensive experience in the pharmaceutical and biotechnology industry, with a strong focus on advancing healthcare for cancer patients.
Current Role at BeiGene
Ezgi Tasdemir, PhD, is currently serving as the General Manager for France and BeLux at BeiGene, a global biotechnology company. Based in Milan, Lombardy, Italy, she began this role in July 2021. In this capacity, she leads operations and manages teams across France, Belgium, and Luxembourg, driving the company's mission of advancing healthcare for cancer patients through innovative treatments.
Previous Experience at Novartis Belux
Before joining BeiGene, Ezgi Tasdemir worked at Novartis Belux as the Business Unit Head for Hospital and Biosimilars at Sandoz from 2020 to 2021. She was responsible for overseeing business operations in Belgium, leveraging her extensive experience in managing biosimilars and hospital-focused therapies.
Career at Novartis Oncology
Between 2011 and 2020, Ezgi Tasdemir held the position of Hematology & Cell and Gene Therapy Business Franchise Head at Novartis Oncology for the EGM region, based in Basel Area, Switzerland. Her role involved strategic leadership and advancement of treatments in hematology and cell and gene therapies, making significant contributions to the field.
Academic Background
Ezgi Tasdemir holds a diverse and comprehensive academic background. She earned her PhD in Oncology from a reputed institution between 2005 and 2009. Additionally, she completed an MSc in Public Health and Health Management with a specialty in Health Marketing from Pierre and Marie Curie University, and an MSc in Oncology with a specialty in Cancer Pharmacology and Therapeutics from Paris-Sud University (Paris XI). She also holds a BSc in Molecular Biology and Genetics from Boğaziçi University.
Research and Early Career
Ezgi Tasdemir began her career in research roles at prominent institutions. She worked as a Research Associate in Oncology at Institut Gustave Roussy in France from 2005 to 2009, and in Genetics at Harvard School of Public Health in Boston, USA, in 2003. These roles provided her with a strong foundation in oncology and genetics research, contributing to her expertise in these fields.
Expertise and Focus Areas
Ezgi Tasdemir brings extensive expertise in various therapeutic areas including Oncology, Malignant Hematology, Benign Hematology, Rare Diseases, Cell and Gene Therapies, Innovative Medicines, Generics, and Biosimilars. She is committed to building high-performing, psychologically safe teams and driving positive disruption in the healthcare industry.